Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 53910-25-1 Chemical Structure| 53910-25-1

Structure of Pentostatin
CAS No.: 53910-25-1

Chemical Structure| 53910-25-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pentostatin can inhibit adenosine deaminase irreversibly with Ki of 2.5 pM, as an antineoplastic anti-metabolite used in the treatment of several forms of leukemia.

Synonyms: CI-825; Deoxycoformycin; PD81565

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pentostatin

CAS No. :53910-25-1
Formula : C11H16N4O4
M.W : 268.27
SMILES Code : O[C@H]1C(N=CN2[C@H](O[C@@H]3CO)C[C@@H]3O)=C2NC=NC1
Synonyms :
CI-825; Deoxycoformycin; PD81565
MDL No. :MFCD00078802
InChI Key :FPVKHBSQESCIEP-JQCXWYLXSA-N
Pubchem ID :439693

Safety of Pentostatin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H350-H360
Precautionary Statements:P264-P270-P301+P310-P321-P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Caco-2 cells 10 µM 120 min To evaluate the stabilising effect of Pentostatin on cordycepin in Caco-2 cells, results showed that Pentostatin inhibited the metabolism of cordycepin. PMC6823370
C57BL/6J mouse red blood cells 500 µM 14 days To study the changes in purine metabolism in red blood cells under hypoxic conditions, results showed that hypoxic conditions reduced purine deaminase activity, decreasing hypoxanthine accumulation. PMC5792281
tRNAAsp 10 µM 5 h To detect the in vitro labelling effect of preQ1 derivatives in tRNA, the results showed that all tested preQ1 ligands were successfully labelled. PMC9561289

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOD-SCID mice U937 cell-inoculated leukemia model Intraperitoneal injection 1 mg/kg Once every two days for three times To investigate the effect of Pentostatin combined with Cordycepin on the survival rate of leukemia mice, the results showed that the combination significantly prolonged the survival rate of mice. PMC5339716
mice inflammatory and neuropathic pain models intraperitoneal injection 50 mg/kg single injection, experiment lasted for 3-3.5 hours To evaluate the clinical potential of Pentostatin as an adjuvant to acupuncture, results showed that Pentostatin significantly enhanced acupuncture-induced adenosine accumulation and prolonged the anti-nociceptive effect of acupuncture. PMC3467968
Mice Neural stem cell-specific Itpa conditional knockout mice Subcutaneous injection 200 or 400 mg/kg/d Once daily for 2 days To evaluate the suppression of audiogenic seizures in Itpa-cKO mice by sodium valproate. Results showed that sodium valproate at 200 mg/kg/d and 400 mg/kg/d reduced the seizure rate to 33.3% and 0%, respectively. PMC7710303

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT03663933 Lymphoproliferative Disorders ... More >> Autoimmune Lymphoproliferative Primary T-cell Immunodeficiency Disorders Immune System Diseases Common Variable Immunodeficiency Less << Phase 2 Recruiting May 1, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01862965 Chronic Graft-versus-host Dise... More >>ase Less << Phase 2 Active, not recruiting June 2018 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07743 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany, 55101 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universitätsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fuer Diagnostik GmbH Wiesbaden, Germany, 65191 Less <<
NCT03112603 Graft-versus-host Disease (GVH... More >>D) Less << Phase 3 Recruiting January 2022 -
NCT02411084 Graft vs Host Disease Phase 3 Terminated(Insufficient rate o... More >>f accrual) Less << - -
NCT01239368 - Terminated(Terminated due to i... More >>nsufficient accrual.) Less << - -
NCT00676806 Leukemia Lymp... More >>homa Multiple Myeloma Aplastic Anemia Less << Phase 2 Terminated(Slow accrual) - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT00676806 - Terminated(Slow accrual) - -
NCT00720785 Chronic Myeloid Leukemia (CML)... More >> Pancreatic Ca Colon/ Rectal Ca Multiple Myeloma Carcinoma, Non-Small -Cell Lung Less << Phase 1 Recruiting January 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02579967 Primary T-cell Immunodeficienc... More >>y Disorders Common Variable Immunodeficiency Immune System Diseases Autoimmune Lymphoproliferative Lymphoproliferative Disorders Less << Phase 2 Recruiting October 21, 2027 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03077542 Sickle Cell Disease Phase 1 Phase 2 Recruiting August 31, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02694770 Steroid-refractory aGvHD Subse... More >>quent to Allogeneic Hematopoietic Cell Transplantation Less << Phase 2 Withdrawn(corporate decision) February 2018 United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03249831 Sickle Cell Disease ... More >> Sickle Cell Disorder Hemoglobinopathies Thalassemia Anemia, Sickle Cell Less << Phase 1 Recruiting December 2022 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Joseph Rosenthal, MD    626-256-4673 ext 88442    jrosenthal@coh.org    Principal Investigator: Joseph Rosenthal, MD Less <<
NCT02883946 - Completed - France ... More >> Chu de Reims Reims, France, 51092 Less <<
NCT02032446 Hematologic Malignancies Phase 1 Phase 2 Recruiting September 2019 Italy ... More >> A O Papa Giovanni XXIII Recruiting Bergamo, Italy, 24127 Contact: Maria Luisa Ferrari, Study coordinator    035.2673681 ext 0039    mlferrari@asst-pg23.it    Sub-Investigator: Alessandra Algarotti, MD          Sub-Investigator: Caterina Micò, MD          Sub-Investigator: Anna Grassi, MD          Ao S Croce E Carle Recruiting Cuneo, Italy, 12100 Contact: NICOLA MORANDINI, MD    +3901716424478    MORANDININ@GMAIL.COM    AO Careggi Not yet recruiting Firenze, Italy, 50134 Contact: Riccardo Saccardi, MD    0557947672    riccardo.saccardi@aou.unifi.it    IRCCS G Gaslini Not yet recruiting Genova, Italy, 16147 Contact: Edoardo Lanino, MD    01056362405    edoardolanino@gaslini.org    Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico Active, not recruiting Milano, Italy, 20122 Clinica Pediatrica San Gerardo Active, not recruiting Monza, Italy, 20900 Azienda Ospedaliero-Universitaria Di Udine Not yet recruiting Udine, Italy, 33100 Contact: RENATO FANIN, MD    +39.0432559662    RENATO.FANIN@UNIUD.IT    Ospedale San Bortolo Active, not recruiting Vicenza, Italy, 36100 Less <<
NCT01239368 Myeloma, Plasma-Cell ... More >> Myeloma-Multiple Myelomatosis Less << Phase 1 Phase 2 Terminated(Terminated due to i... More >>nsufficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health (NIH) Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00045305 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts-NEMC Cancer Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Ohio Jewish Hospital Cancer Center Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00045305 - Completed - -
NCT00057954 Lymphoma Phase 2 Terminated(Slow accrual) - United States, Colorado ... More >> Aurora Presbyterian Hospital Aurora, Colorado, United States, 80012 Boulder Community Hospital Boulder, Colorado, United States, 80301-9019 Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States, 80933 Porter Adventist Hospital Denver, Colorado, United States, 80210 Presbyterian - St. Luke's Medical Center Denver, Colorado, United States, 80218 St. Joseph Hospital Denver, Colorado, United States, 80218 Rose Medical Center Denver, Colorado, United States, 80220 CCOP - Colorado Cancer Research Program Denver, Colorado, United States, 80224-2522 Swedish Medical Center Englewood, Colorado, United States, 80110 St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction, Colorado, United States, 81502 Sky Ridge Medical Center Lone Tree, Colorado, United States, 80124 Hope Cancer Care Center at Longmont United Hospital Longmont, Colorado, United States, 80502 St. Mary - Corwin Regional Medical Center Pueblo, Colorado, United States, 81004 North Suburban Medical Center Thornton, Colorado, United States, 80229 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts-NEMC Cancer Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02105766 Sickle Cell Disease ... More >> Thalassemia Stem Cell Transplantation Graft vs Host Disease Less << Phase 2 Recruiting August 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00006968 Kidney Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 Less <<
NCT00049413 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, California ... More >> Hoag Cancer Center at Hoag Memorial Hospital Presbyterian Newport Beach, California, United States, 92658 Less <<
NCT00224874 Graft vs Host Disease ... More >> Immune System Disorders Less << Phase 2 Completed - -
NCT01416974 Leukemia Phase 1 Active, not recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00057954 - Terminated(Slow accrual) - -
NCT00923845 - Completed - -
NCT00923845 Renal Cell Carcinoma ... More >> Graft-Versus-Host Disease Engraftment Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00131313 Chronic Lymphocytic Leukemia Phase 4 Unknown - -
NCT00074282 Leukemia Phase 2 Unknown - -
NCT00816413 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Nonmalignant Neoplasm Less << Phase 1 Phase 2 Withdrawn(Screenings yielded i... More >>nadequate eligible subjects to enroll.) Less << - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT00224874 - Completed - -
NCT00546377 - Completed - -
NCT00402714 Hematologic Malignancies Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Massachusetts Tufts-New England Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Methodist Hospital - Texas Transplant Institute San Antonio, Texas, United States, 78229 Less <<
NCT01362790 Mesothelioma ... More >>Adenocarcinoma of Lung Pancreatic Neoplasms Less << Phase 1 Phase 2 Unknown September 4, 2017 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00546377 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00003658 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00402714 - Completed - -
NCT00602836 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00026351 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, California ... More >> Cancer and Blood Institute of the Desert Rancho Mirage, California, United States, 92270 Redding Medical Center Redding, California, United States, 96001 United States, Maryland Oncology-Hematology Associates, P.A. Clinton, Maryland, United States, 20735 United States, New York North Shore Hematology/Oncology Associates, P.C. East Setauket, New York, United States, 11733 Hematology Oncology Associates of Central New York, P.C. Syracuse, New York, United States, 13210 Less <<
NCT01024010 Chronic Lymphocytic Leukemia ... More >> Stage 0 Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01024010 - Completed - -
NCT00032773 Acute Graft Versus Host Diseas... More >>e Less << Phase 1 Phase 2 Terminated - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States Less <<
NCT00602836 - Completed - -
NCT01460602 Follicular Lymphoma ... More >> Marginal Zone Lymphoma Mantle Cell Lymphoma Less << Phase 1 Phase 2 Terminated(Investigator has re... More >>located to MD Anderson) Less << October 2014 United States, Louisiana ... More >> LSU - Shreveport Health Sciences Center, Feist-Weiller Cancer Center Shreveport, Louisiana, United States, 71103 Less <<
NCT00496873 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00816595 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00927797 Immunocytoma/Morbus Waldenstr?... More >>m B-Cell Non-Hodgkin's Lymphoma B-Cell Chronic Lymphocytic Leukemia Less << Phase 2 Unknown January 2012 -
NCT00816595 - Completed - -
NCT00254163 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 3 Completed - United States, Florida ... More >> Cancer Centers of Florida, P.A. Ocoee, Florida, United States, 34761 United States, Indiana Hope Center Terre Haute, Indiana, United States, 47802 United States, Maryland Alliance Hematology Oncology PA Westminster, Maryland, United States, 21157 United States, Missouri St Joseph Oncology, Inc St Joseph, Missouri, United States, 64507 United States, New York New York Oncology Hematology, PC Albany, New York, United States, 12208 United States, North Carolina Northwestern Carolina Oncology Hemato Hickory, North Carolina, United States, 28602 United States, Pennsylvania Medical Oncology Associates Kingston, Pennsylvania, United States, 18704 United States, Texas South Texas Cancer Center-McAllen McAllen, Texas, United States, 78503 Texas Oncology Cancer Center-Sugar Land Sugar Land, Texas, United States, 77479 United States, Washington Cancer Care Northwest-South Spokane, Washington, United States, 99202 Yakima Valley Mem Hosp/North Star Lodge Yakima, Washington, United States, 98902 Less <<
NCT00669318 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Iowa ... More >> Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT00201721 B-Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00496873 - Completed - -
NCT00096161 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Graft Versus Host Disease Hodgkin Lymphoma Myelodysplastic/Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Plasma Cell Myeloma Waldenstrom Macroglobulinemia Less << Phase 2 Active, not recruiting - United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00571662 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndromes Multiple Myeloma Non-Hodgkins Lymphoma Hodgkins Disease Peripheral T-cell Lymphoma Less << Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States, 68198 Less <<
NCT00096161 - Active, not recruiting - -
NCT00541034 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00571662 - Completed - -
NCT00669318 - Completed - -
NCT00003005 Leukemia Phase 1 Completed - United States, District of Col... More >>umbia Vincent T. Lombardi Cancer Research Center, Georgetown University Washington, District of Columbia, United States, 20007 United States, Maryland Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 United States, Massachusetts New England Medical Center Hospital Boston, Massachusetts, United States, 02111 Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Boston Medical Center Boston, Massachusetts, United States, 02118 University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University Barnard Cancer Center Saint Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210 United States, Oregon Oregon Cancer Center at Oregon Health Sciences University Portland, Oregon, United States, 97201-3098 Less <<
NCT00254163 - Completed - -
NCT00496340 Hematologic Malignancies Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00541034 - Completed - -
NCT00074035 Graft Versus Host Disease Phase 2 Completed - United States, Delaware ... More >> Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Illinois University of Illinois Cancer Center Chicago, Illinois, United States, 60612-7243 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital Cancer Program at Union Hospital Elkton, Maryland, United States, 21921 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States, 19111-2497 Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00074035 - Completed - -
NCT00698685 Leukemia Lymp... More >>homa Hodgkin's Disease Hematologic Neoplasms Multiple Myeloma Carcinoma, Renal Cell Less << Phase 2 Terminated(Pentostatin/alemtuz... More >>umab regimen had greater risk of graft failure.) Less << - United States, Arizona ... More >> Arizona Cancer Center at UMC North/University Medical Center Tucson, Arizona, United States, 85724 Arizona Cancer Center at UMC North Tucson, Arizona, United States, 85724 Less <<
NCT01059786 Hairy Cell Leukemia Phase 2 Recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00506922 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00496340 - Completed - -
NCT00709215 Refractory TdT-Positive Leukem... More >>ia Less << Phase 1 Phase 2 Unknown December 2010 United States, Massachusetts ... More >> Brigham & Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Daniel J DeAngelo, MD, PhD.    617-632-2645    Daniel_Deangelo@dfci.harvard.edu    Principal Investigator: Daneil J DeAngelo, MD, PhD.          Sub-Investigator: Richard Stone, MD          Sub-Investigator: L. Andres Sirulnik, MD          Sub-Investigator: Martha Wadleigh, MD          Sub-Investigator: Gregory Abel, MD, MPH          Sub-Investigator: Susan L Buchanan, PA          Sub-Investigator: Adriana Penicaud, PA          Sub-Investigator: Ilene Galinsky, APRN          Sub-Investigator: Eyal Attar, MD          Sub-Investigator: Philip Amrein, MD          Sub-Investigator: Karen Kuhn Ballen, MD          United States, Texas Cancer Therapy Reasearch Center at UTHSCA Recruiting San Antonio, Texas, United States, 78229 Contact: Swaminathan Padmanabhan, MD    210-450-5094    PadmanabhanS@uthscsa.edu    Sub-Investigator: Monica Mita, MD          Principal Investigator: Alain Mita, MD Less <<
NCT00038025 Peripheral T-cell Lymphoma ... More >> Cutaneous T-cell Lymphoma Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00506922 - Completed - -
NCT00453193 Lymphoma Leuk... More >>emia Less << Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01352312 Chronic Lymphocytic Leukemia ... More >> B-Cell Non-Hodgkin's Lymphoma Less << Phase 1 Terminated(Insufficient accrua... More >>l over 12 mo period) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01001780 Active Chronic Graft Versus Ho... More >>st Disease Less << Phase 2 Withdrawn(Study stopped early ... More >>due to poor accrual.) Less << - United States, New York ... More >> University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00698685 - Terminated(Pentostatin/alemtuz... More >>umab regimen had greater risk of graft failure.) Less << - -
NCT01681563 Chronic Lymphocytic Leukemia Phase 2 Completed - Italy ... More >> Azienda Ospedaliera San Gerardo di Monza U.O. Ematologia Monza, MB, Italy, 20052 IRCCS Istituto clinico Humanitas di Rozzano Dipartimento di Ematologia Rozzano, Milano, Italy, 20089 Azienda Ospedaliera Ospedale Civile di Legnano U.O. Medicina Interna Legnano, MI, Italy, 20025 A.O. Papa Giovanni XXIII U.S.C. Ematologia Bergamo, Italy, 24128 Presidi Ospedalieri Spedali Civili di Brescia Divisione di Ematologia Brescia, Italy, 25125 Ospedale Valduce S.C. Medicina Interna Sez. Ematologia Como, Italy, 22100 Ospedale Maggiore Policlinico Università di Milano Istituto di Ematologia Milano, Italy, 20122 IRCCS Fondazione Centro S. Raffaele del Monte Tabor Università Vita-Salute Dipartimento di Medicina Interna Milano, Italy, 20132 Ospedale Cà Granda - Niguarda S.C: Ematologia Milano, Italy, 20162 Azienda ospedaliera-universitaria Maggiore della Carità SCDU Ematologia Novara, Italy, 28100 IRCCS Policlinico San Matteo Pavia Istituto di Ematologia Pavia, Italy, 27100 A.O.U. Città della Salute e della Scienza Ospedale Molinette Divisione di Ematologia Torino, Italy, 10126 Less <<
NCT00201786 Graft-Versus-Host Disease PHASE2 COMPLETED 2025-07-13 Ohio State University, Columbu... More >>s, Ohio, 43210, United States Less <<
NCT01188798 Acute Lymphoblastic Leukemia ... More >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Hodgkin's Disease Myelodysplastic Syndrome Less << Phase 3 Completed - United States, Tennessee ... More >> St . Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01188798 - Completed - -
NCT00453193 - Terminated(Slow accrual.) - -
NCT00144430 Graft vs Host Disease PHASE2 COMPLETED 2025-08-08 Loma Linda University Medical ... More >>Center, Loma Linda, California, 92350, United States|Pediatric Medical Center for Northern California, Oakland, California, 94609, United States|Nemour's Children's Clinic, Jacksonville, Florida, 32007, United States|University of Miami, Miami, Florida, 33136, United States|All Children's Health System, St. Petersburg, Florida, 33701, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Children's Memorial Hospital, Chicago, Illinois, 60614, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|LSUHSC, New Orleans, Louisiana, 70112, United States|John's Hopkins, Baltimore, Maryland, 21287, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|DeVos Children's Hospital, Grand Rapids, Michigan, 49503, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|St. Louis University, St. Louis, Missouri, 63104, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07602, United States|Columbia Presbyterian Medical Center, New York, New York, 10032-3702, United States|New York Medical College, Valhalla, New York, 10595, United States|Rainbow Babies and Children's, Cleveland, Ohio, 44106, United States|Columbus Children's Hospital, Columbus, Ohio, 43205, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Victor Aquino, MD, Dallas, Texas, 75390, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Southwest Texas Methodist Hospital, San Antonio, Texas, 78229, United States|University of Utah, Salt Lake City, Utah, 84132, United States Less <<
NCT00915850 Esophageal Cancer PHASE1|PHASE2 UNKNOWN 2025-08-15 Wakayama Medical University, W... More >>akayama, 641-8510, Japan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.73mL

0.75mL

0.37mL

18.64mL

3.73mL

1.86mL

37.28mL

7.46mL

3.73mL

References

 

Historical Records

Categories